These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8028741)

  • 1. [Immunological indices in myelodysplastic syndromes].
    Luraschi A; Saglietti G; Fedeli P; Gioria A; Della Vedova A; Ferrari V; Borgotti P
    Minerva Med; 1994 Apr; 85(4):145-53. PubMed ID: 8028741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic studies in myelodysplastic syndrome].
    Molnár L; Burger T; Schmelczer M; Fábián G
    Orv Hetil; 1991 Oct; 132(42):2299-302. PubMed ID: 1945366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
    Kiladjian JJ; Visentin G; Viey E; Chevret S; Eclache V; Stirnemann J; Bourhis JH; Chouaib S; Fenaux P; Caignard A
    Haematologica; 2008 Mar; 93(3):381-9. PubMed ID: 18268282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelodysplastic syndrome: experience of the Study and Treatment of Bone Marrow Failure Group].
    Goldztein S; Nucifora E; Blasetti A; Fantl D; González N; Saslavsky J; Annetta I; Calahonra R; Binaghi A; de Di Risio CB
    Medicina (B Aires); 1990; 50(3):189-97. PubMed ID: 2130204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
    Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
    Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
    Wu L; Li X; Chang C; Ying S; He Q; Pu Q
    Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of Th cell subsets in bone marrow of myelodysplastic syndromes patients].
    Wang XL; Shao ZH; Yao C; He GS; Liu H; Shi J; Bai J; Cao YR; Tu MF; Wang HQ; Xing LM; Sun J; Jia HR; Yang CL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):743-5. PubMed ID: 16620580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on the activity and quantity of natural killer cells and T lymphocytes in myelodysplastic syndrome patients].
    Tan LJ; Pang GY; Hong WD
    Zhonghua Nei Ke Za Zhi; 1993 May; 32(5):319-21. PubMed ID: 8269761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
    Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.
    Marisavljević D; Kraguljac N; Rolović Z
    Med Oncol; 2006; 23(3):385-91. PubMed ID: 17018896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of lymphocyte subpopulations and cytokine-producing activity of blood cells in patients with primary myelodysplastic syndrome].
    Gritsaev SV; Rozanova OE; Abdulkadyrov KM; Bubnova LN; Tiranova SA
    Vopr Onkol; 2005; 51(5):563-6. PubMed ID: 16756011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
    Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
    Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological abnormalities in myelodysplastic syndromes.
    Hamblin TJ
    Semin Hematol; 1996 Apr; 33(2):150-62. PubMed ID: 8722685
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
    Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
    Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell clonality in myelodysplastic syndrome].
    Krejcová H; Neuwirtová R; Cermák J; Belicková M; Brdicka R
    Sb Lek; 2002; 103(3):339-48. PubMed ID: 12688178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.